2-fluoro-araatp has been researched along with clofarabine in 1 studies
| Studies (2-fluoro-araatp) | Trials (2-fluoro-araatp) | Recent Studies (post-2010) (2-fluoro-araatp) | Studies (clofarabine) | Trials (clofarabine) | Recent Studies (post-2010) (clofarabine) |
|---|---|---|---|---|---|
| 22 | 2 | 2 | 424 | 101 | 280 |
| Protein | Taxonomy | 2-fluoro-araatp (IC50) | clofarabine (IC50) |
|---|---|---|---|
| cGMP-dependent 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 3.12 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keating, MJ; Nowak, BJ; Plunkett, W; Yamauchi, T | 1 |
1 other study(ies) available for 2-fluoro-araatp and clofarabine
| Article | Year |
|---|---|
DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine.
Topics: Adenine Nucleotides; Antineoplastic Agents; Apoptosis; Arabinonucleosides; Arabinonucleotides; Clofarabine; Cyclophosphamide; DNA; DNA Repair; Dose-Response Relationship, Drug; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Nucleosides; Time Factors; Vidarabine | 2001 |